{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:49:23Z","timestamp":1792619363775,"version":"4.5.0"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare, heterogeneous, but treatable autoimmune-mediated peripheral neuropathy characterized by demyelination. CIDP can occur independently or simultaneously with a variety of diseases such as diabetes, monoclonal gammopathy of undetermined significance (MGUS), connective tissue disease, and HIV. It is important to identify CIDP and specific peripheral neuropathies caused by these diseases; this review aims to summarize the CIDP literatures related to diabetes, MGUS, SLE, and HIV, and to be helpful for the management of such patients.<\/jats:p>","DOI":"10.3389\/fimmu.2022.890142","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T05:54:19Z","timestamp":1656914059000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Association With Concomitant Diseases: Identification and Management"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30144-9","article-title":"Progress in Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy","volume":"18","author":"Bunschoten","year":"2019","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.03.026","article-title":"History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy","volume":"93","author":"Dyck","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309697","article-title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy: From Pathology to Phenotype","volume":"86","author":"Mathey","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-67-5-1007","article-title":"Guillain-Barre Syndrome With Slow Progressive Onset and Persistent Elevation of Spinal Fluid Protein","volume":"67","author":"Hinman","year":"1967","journal-title":"Ann Intern Med"},{"key":"B5","article-title":"Chronic Inflammatory Polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/157339912800564034","article-title":"Common and Less Common Peripheral Nerve Disorders Associated With Diabetes","volume":"8","author":"Knopp","year":"2012","journal-title":"Curr Diabetes Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2010.00278.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on Management of Paraproteinemic Demyelinating Neuropathies","volume":"15","author":"Joint","year":"2010","journal-title":"Rep Joint Task Force Eur Fed Neurol Societies Peripheral Nerve Soc \u2013 First Rev J Peripheral Nervous System"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11055-007-0141-1","article-title":"Peripheral Nervous System Lesion Syndromes and the Mechanisms of Their Formation in Connective Tissue Diseases","volume":"37","author":"Spirin","year":"2007","journal-title":"Neurosci Behav Physiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.5.658","article-title":"Vasculitic Polyradiculopathy in Systemic Lupus Erythematosus","volume":"66","author":"Stefurak","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force-Second Revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur J Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323615","article-title":"Frequency of Diabetes and Other Comorbidities in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Their Impact on Clinical Presentation and Response to Therapy","volume":"91","author":"Doneddu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-320314","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy: Update on Diagnosis, Immunopathogenesis and Treatment","volume":"90","author":"Lehmann","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in Chronic Inflammatory Neuropathies: Diagnostic and Therapeutic Implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000494291","article-title":"Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis","volume":"52","author":"Broers","year":"2019","journal-title":"Neuroepidemiology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21206","article-title":"Epidemiologic Variability of Chronic Inflammatory Demyelinating Polyneuropathy With Different Diagnostic Criteria: Study of a UK Population","volume":"39","author":"Rajabally","year":"2009","journal-title":"Muscle Nerve"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14044","article-title":"Risk Factors for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Antecedent Events, Lifestyle and Dietary Habits","volume":"27","author":"Doneddu","year":"2020","journal-title":"Data Ital CIDP Database Eur J Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24496","article-title":"Which Criteria for Research in Chronic Inflammatory Demyelinating Polyradiculoneuropathy","volume":"51","author":"Rajabally","year":"2015","journal-title":"Anal Curr Practice Muscle Nerve"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25368","article-title":"MR Neurography for the Evaluation of CIDP","volume":"55","author":"Ishikawa","year":"2017","journal-title":"Muscle Nerve"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003443","article-title":"MRI of the Cervical Nerve Roots in the Diagnosis of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Single-Institution, Retrospective Case\u2013Control Study","volume":"3","author":"Tanaka","year":"2013","journal-title":"BMJ Open"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23624","article-title":"Nerve Ultrasound in a Case of Chronic Inflammatory Demyelinating Neuropathy","volume":"47","author":"Kerasnoudis","year":"2013","journal-title":"Muscle Nerve"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.7.1383","article-title":"Spinal Root and Plexus Hypertrophy in Chronic Inflammatory Demyelinating Polyneuropathy","volume":"122","author":"Duggins","year":"1999","journal-title":"Brain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"109164","DOI":"10.1016\/j.ejrad.2020.109164","article-title":"MRI Quantifies Lumbosacral Nerve Root and Sciatic Nerve Hypertrophy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy","volume":"130","author":"Shah","year":"2020","journal-title":"Eur J Radiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/acn3.502","article-title":"MRI Biomarkers of Proximal Nerve Injury in CIDP","volume":"5","author":"Lichtenstein","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008697","article-title":"Diagnostic Accuracy of MRI and Ultrasound in Chronic Immune-Mediated Neuropathies","volume":"94","author":"Oudeman","year":"2020","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10485-x","article-title":"Changes of Clinical, Neurophysiological and Nerve Ultrasound Characteristics in CIDP Over Time: A 3-Year Follow-Up","volume":"268","author":"Fionda","year":"2021","journal-title":"J Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001291","article-title":"Peripheral Nerve Ultrasound Changes in CIDP and Correlations With Nerve Conduction Velocity","volume":"84","author":"Di Pasquale","year":"2015","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000595","article-title":"Management of Chronic Inflammatory Demyelinating Polyradiculopathy","volume":"31","author":"Doneddu","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","article-title":"Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy (PATH): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial","volume":"17","author":"van Schaik","year":"2018","journal-title":"Lancet Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e590","DOI":"10.1212\/NXI.0000000000000590","article-title":"Long-Term Safety and Efficacy of Subcutaneous Immunoglobulin IgPro20 in CIDP: PATH Extension Study","volume":"6","author":"van Schaik","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01117-3","article-title":"Novel Immunological and Therapeutic Insights in Guillain-Barre Syndrome and CIDP","volume":"18","author":"Querol","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s42466-020-00088-8","article-title":"Comprehensive Approaches for Diagnosis, Monitoring and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy","volume":"2","author":"Fisse","year":"2020","journal-title":"Neurol Res Pract"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316271","article-title":"Autologous Haematopoietic Stem Cell Transplantation for Neurological Diseases","volume":"89","author":"Burman","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306014","article-title":"Autologous Haematopoietic Stem Cell Transplantation: A Viable Treatment Option for CIDP","volume":"85","author":"Press","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11910-014-0473-5","article-title":"Diabetic Neuropathy: Mechanisms, Emerging Treatments, and Subtypes","volume":"14","author":"Albers","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.05.007","article-title":"The Dilemma of Diabetes in Chronic Inflammatory Demyelinating Polyneuropathy","volume":"30","author":"Bril","year":"2016","journal-title":"J Diabetes Compl"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.5.758","article-title":"Demyelinating Neuropathy in Diabetes Mellitus","volume":"59","author":"Sharma","year":"2002","journal-title":"Arch Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<37::AID-MUS5>3.0.CO;2-9","article-title":"Influence of Diabetes Mellitus on Chronic Inflammatory Demyelinating Polyneuropathy","volume":"23","author":"Gorson","year":"2000","journal-title":"Muscle Nerve"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-2457(98)00028-5","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy in Diabetics: Motor Conductions are Important in the Differential Diagnosis With Diabetic Polyneuropathy","volume":"110","author":"Uncini","year":"1999","journal-title":"Clin Neurophysiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0022-510X(96)00126-8","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Diabetics","volume":"142","author":"Stewart","year":"1996","journal-title":"J Neurol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-322971","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy Associated With Diabetes: A European Multicentre Comparative Reappraisal","volume":"91","author":"Rajabally","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02598.x","article-title":"Comorbidity Between CIDP and Diabetes Mellitus: Only a Matter of Chance","volume":"16","author":"Chi\u00f2","year":"2009","journal-title":"Eur J Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1212\/WNL.0b013e3181aaea47","article-title":"Incidence and Prevalence of CIDP and the Association of Diabetes Mellitus","volume":"73","author":"Laughlin","year":"2009","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.177","article-title":"Comparison of Diabetes Patients With \"Demyelinating\" Diabetic Sensorimotor Polyneuropathy to Those Diagnosed With CIDP","volume":"3","author":"Dunnigan","year":"2013","journal-title":"Brain Behav"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2011.00299.x","article-title":"Biomarkers of CIDP in Patients With Diabetes or CMT1","author":"Latov","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000096174.86850.7F","article-title":"Diagnostic Value of Sural Nerve Matrix Metalloproteinase-9 in Diabetic Patients With CIDP","volume":"61","author":"Jann","year":"2003","journal-title":"Neurology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089344","article-title":"The Characteristics of Chronic Inflammatory Demyelinating Polyneuropathy in Patients With and Without Diabetes\u2013an Observational Study","volume":"9","author":"Dunnigan","year":"2014","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1250","article-title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Diabetic Patients","volume":"27","author":"Haq","year":"2003","journal-title":"Muscle Nerve"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.01.007","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy Mimicking Diabetic Neuropathy in a Young Female With Type 2 Diabetes Mellitus","volume":"96","author":"Wang","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-543X.2005.00130.x","article-title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Two Children With Type 1 Diabetes Mellitus","volume":"6","author":"Fudge","year":"2005","journal-title":"Pediatr Diabetes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12974-021-02130-1","article-title":"Corneal Confocal Microscopy Differentiates Inflammatory From Diabetic Neuropathy","volume":"18","author":"Fleischer","year":"2021","journal-title":"J Neuroinflamm"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12394","article-title":"Diagnostic Criteria of Chronic Inflammatory Demyelinating Polyneuropathy in Diabetes Mellitus","volume":"132","author":"Lotan","year":"2015","journal-title":"Acta Neurol Scandinavica"},{"key":"B52","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrneurol.2017.123","article-title":"CIDP and Other Inflammatory Neuropathies in Diabetes \u2014 Diagnosis and Management","volume":"13","author":"Rajabally","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20391","article-title":"Different Types of Chronic Inflammatory Demyelinating Polyneuropathy Have a Different Clinical Course and Response to Treatment","volume":"32","author":"Jann","year":"2005","journal-title":"Muscle Nerve"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.149013","article-title":"Intravenous Immunoglobulin Is Effective in Patients With Diabetes and With Chronic Inflammatory Demyelinating Polyneuropathy: Long Term Follow-Up","volume":"80","author":"Jann","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-0698-0","article-title":"Intravenous Immunoglobulin as First Treatment in Diabetics With Concomitant Distal Symmetric Axonal Polyneuropathy and CIDP","volume":"249","author":"Cocito","year":"2002","journal-title":"J Neurol"},{"key":"B56","first-page":"14","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy in a Diabetic Patient: Deterioration After Intravenous Immunoglobulins Treatment and Favorable Response to Steroid Treatment","volume":"107","author":"Pedersen","year":"2007","journal-title":"Acta Neurol Belgica"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139674","article-title":"Treatment Responsiveness in CIDP Patients With Diabetes Is Associated With Higher Degrees of Demyelination","volume":"10","author":"Abraham","year":"2015","journal-title":"PloS One"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1018891","article-title":"Treatment Responsiveness in CIDP Patients With Diabetes is Associated With Unique Electrophysiological Characteristics, and Not With Common Criteria for CIDP","volume":"11","author":"Abraham","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-004-0048-y","article-title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Diabetes Mellitus","volume":"4","author":"Ayyar","year":"2004","journal-title":"Curr Diabetes Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.5.751","article-title":"Diabetic Demyelinating Polyneuropathy Responsive to Intravenous Immunoglobulin Therapy","volume":"59","author":"Sharma","year":"2002","journal-title":"Arch Neurol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.02.027","article-title":"Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy Associated With Diabetes Mellitus","volume":"256","author":"M\u00fcnch","year":"2007","journal-title":"J Neurol Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12883-016-0532-4","article-title":"Paraproteinemic Neuropathy: A Practical Review","volume":"16","author":"Rison","year":"2016","journal-title":"BMC Neurol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52902-2.00025-4","article-title":"Neuropathy and Monoclonal Gammopathy","volume":"115","author":"Nobile-Orazio","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11940-017-0479-9","article-title":"Advances in the Treatment of Paraproteinemic Neuropathy","volume":"19","author":"Nobile-Orazio","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"16769","DOI":"10.1038\/s41598-019-53289-w","article-title":"Distinctive Patterns of Peripheral Neuropathy Across the Spectrum of Plasma Cell Disorders","volume":"9","author":"Byun","year":"2019","journal-title":"Sci Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.2.321","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy: Clinical Features and Response to Treatment in 67 Consecutive Patients With and Without a Monoclonal Gammopathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/118.2.359","article-title":"Long-Term Follow-Up of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Without and With Monoclonal Gammopathy","volume":"118","author":"Simmons","year":"1995","journal-title":"Brain"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.6.1157","article-title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Comparison of Patients With and Without an Associated Monoclonal Gammopathy","volume":"42","author":"Bromberg","year":"1992","journal-title":"Neurology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.01.055","article-title":"Ultrasound of the Nerves - An Appropriate Addition to Nerve Conduction Studies to Differentiate Paraproteinemic Neuropathies","volume":"362","author":"Athanasopoulou","year":"2016","journal-title":"J Neurol Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<73::AID-MUS9>3.0.CO;2-5","article-title":"Diagnostic Criteria for Demyelinating Polyneuropathy Associated With Monoclonal Gammopathy","volume":"23","author":"Notermans","year":"2000","journal-title":"Muscle Nerve"},{"key":"B71","doi-asserted-by":"publisher","first-page":"CD002827","DOI":"10.1002\/14651858.CD002827.pub4","article-title":"Immunotherapy for IgM Anti-Myelin-Associated Glycoprotein Paraprotein-Associated Peripheral Neuropathies","volume":"10","author":"Lunn","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"CD002827","DOI":"10.1002\/14651858.CD002827.pub3","article-title":"Immunotherapy for IgM Anti-Myelin-Associated Glycoprotein Paraprotein-Associated Peripheral Neuropathies","author":"Lunn","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical Spectrum of Chronic Acquired Demyelinating Polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2003.00127.x","article-title":"Different Clinical, Electrophysiological and Immunological Features of CIDP Associated With Paraproteinaemia","volume":"108","author":"Cocito","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.5.766","article-title":"Efficacy of Intravenous Immunoglobulin in Patients With IgG Monoclonal Gammopathy and Polyneuropathy","volume":"59","author":"Gorson","year":"2002","journal-title":"Arch Neurol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"CD005376","DOI":"10.1002\/14651858.CD005376.pub3","article-title":"Treatment for IgG and IgA Paraproteinaemic Neuropathy","author":"Stork","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-000889","article-title":"A Case of Severe Chronic Inflammatory Demyelinating Polyradiculoneuropathy With Monoclonal Gammopathy of Undetermined Significance With Alternating Immunoglobulin Class to IgM From IgA","volume":"56","author":"Hayashi","year":"2016","journal-title":"Rinsho Shinkeigaku"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e04230","DOI":"10.1016\/j.heliyon.2020.e04230","article-title":"Severe CIDP-MGUS Responsive to Rituximab","volume":"6","author":"Posa","year":"2020","journal-title":"Heliyon"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000888","article-title":"A Case of CIDP Concurrent With MGUS IgG Kappa Responsive to Autologous Stem Cell Transplantation","volume":"7","author":"Colucci","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B80","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/art.41070","article-title":"Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study","volume":"72","author":"Hanly","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B81","article-title":"SLE Neuropathy-Anything New","volume":"63","author":"Londhey","year":"2015","journal-title":"J Assoc Physicians India"},{"key":"B82","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology Nomenclature and Case Definitions for Neuropsychiatric Lupus Syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319828499","article-title":"Peripheral Nervous System Involvement in Systemic Lupus Erythematosus: A Review of the Evidence","volume":"37","author":"Bortoluzzi","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1600-0404.1991.tb03971.x","article-title":"Serum Antibodies to GM1 and GM3-Gangliosides in Systemic Lupus Erythematosus With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","volume":"83","author":"Sindern","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"B85","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/OARRR.S204109","article-title":"Guillain-Barre Syndrome as the First Manifestation of Juvenile Systemic Lupus Erythematosus: A Case Report","volume":"11","author":"Javadi Parvaneh","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/mus.22129","article-title":"Systemic Lupus Erythematosus Associated Relapsing Polyneuropathy: Recurrent Guillain-Barre Syndrome or Chronic Inflammatory Demyelinating Polyradiculoneuropathy","volume":"44","author":"Zhang","year":"2011","journal-title":"Muscle Nerve"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.08.008","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy in Patients With Systemic Lupus Erythematosus: Prognosis and Outcome","volume":"35","author":"Vina","year":"2005","journal-title":"Semin Arthritis Rheumatism"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.09.018","article-title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated With Systemic Lupus Erythematosus","volume":"51","author":"Julio","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.903541","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): An Uncommon Manifestation of Systemic Lupus Erythematosus (SLE)","volume":"18","author":"Abraham","year":"2017","journal-title":"Am J Case Rep"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1008-2","article-title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy in a Boy With Systemic Lupus Erythematosus","volume":"30","author":"Zoilo","year":"2010","journal-title":"Rheumatol Int"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312440346","article-title":"Successful Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Systemic Lupus Erythematosus (SLE) With Oral Cyclophosphamide","volume":"21","author":"Jasmin","year":"2012","journal-title":"Lupus"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2130-5","article-title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy in a Patient With Systemic Lupus Erythematosus and Good Outcome With Rituximab Treatment","volume":"32","author":"Sanz","year":"2012","journal-title":"Rheumatol Int"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52902-2.00029-1","article-title":"HIV Peripheral Neuropathy","volume":"115","author":"Gabbai","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2015.11.013","article-title":"CIDP in a HIV Endemic Population: A Prospective Case Series From Johannesburg, South Africa","volume":"363","author":"Mochan","year":"2016","journal-title":"J Neurol Sci"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000315","article-title":"A Comparative Study of CIDP in a Cohort of HIV-Infected and HIV-Uninfected Patients","volume":"4","author":"Moodley","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e899","DOI":"10.7759\/cureus.899","article-title":"Multiple Myeloma Associated Chronic Inflammatory Demyelinating Polyradiculoneuropathy: The Importance of Continued Surveillance","volume":"8","author":"Fasanya","year":"2016","journal-title":"Cureus"},{"key":"B97","doi-asserted-by":"publisher","first-page":"117305","DOI":"10.1016\/j.jns.2020.117305","article-title":"Two Distinct Mechanisms of Neuropathy in Immunoglobulin Light Chain (AL) Amyloidosis","volume":"421","author":"Koike","year":"2021","journal-title":"J Neurol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/CND.0000000000000298","article-title":"What Is in the Literature","volume":"22","author":"Bromberg","year":"2020","journal-title":"J Clin Neuromuscul Dis"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05583-7","article-title":"Paraproteinemia and Neuropathy","volume":"42","author":"Koike","year":"2021","journal-title":"Neurol Sci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09688-0","article-title":"Expert Consensus Recommendations to Improve Diagnosis of ATTR Amyloidosis With Polyneuropathy","volume":"268","author":"Adams","year":"2021","journal-title":"J Neurol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324012","article-title":"Early VEGF Testing in Inflammatory Neuropathy Avoids POEMS Syndrome Misdiagnosis and Associated Costs","volume":"92","author":"Marsh","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.890142\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T05:54:26Z","timestamp":1656914066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.890142\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":101,"alternative-id":["10.3389\/fimmu.2022.890142"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.890142","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"article-number":"890142"}}